Latest Market Outlook News

Page 12 of 38
Latrobe Magnesium Limited (ASX – LMG) has launched an $8 million equity raising to fund the ramp-up of its magnesium metal production and advance feasibility studies for a larger commercial plant. The company’s patented hydromet process converts brown coal ash into sustainable magnesium with significantly lower emissions than global peers.
Maxwell Dee
Maxwell Dee
13 Oct 2025
IsoEnergy Ltd. is set to acquire Toro Energy Ltd., combining two significant uranium portfolios to create a diversified global player with flagship projects in Australia, Canada, and the U.S. This strategic merger positions the new entity to capitalize on rising uranium demand amid a tightening market.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Melbana Energy has significantly upgraded its prospective resource estimates for the AC/P70 offshore permit, boosting gas and oil volumes and advancing the Hadrosaurus lead to prospect status, while progressing a farmout process to fund exploration.
Maxwell Dee
Maxwell Dee
10 Oct 2025
Pacific Smiles Group has agreed to an unconditional $2.20 per share cash takeover offer from its majority shareholder Genesis Bidco, representing a 37.5% premium. The Independent Board Committee recommends shareholders accept the offer, pending no superior proposal and ongoing fairness confirmation.
Ada Torres
Ada Torres
10 Oct 2025
LDR Assets, led by the Lederer Family Office, updates its $0.70 per security takeover offer for Elanor Commercial Property Fund, highlighting management concerns and urging investors to accept before the 13 October deadline.
Eva Park
Eva Park
9 Oct 2025
Winsome Resources has resolved a regulatory hurdle to receive 17.65 million shares in Power Metals Corp, increasing its stake to 16.15% and reinforcing its position in critical minerals. Combined with a strong cash balance, this move strengthens Winsome’s liquidity and strategic outlook.
Maxwell Dee
Maxwell Dee
8 Oct 2025
Immuron Limited has taken a significant step forward by submitting an Investigational New Drug application to the FDA for IMM-529, targeting Clostridioides difficile infection. The company aims to start Phase 2 trials in early 2026, addressing a critical unmet need in infectious disease treatment.
Ada Torres
Ada Torres
8 Oct 2025
Mesoblast Limited reports a robust 66% increase in Ryoncil revenues for Q2 2025, driven by strong market adoption and new Medicare reimbursement codes.
Ada Torres
Ada Torres
7 Oct 2025
dorsaVi reports a striking 15-fold increase in US Physical Therapy clinic subscriptions for its ViMove+ product, driven by strong surgeon endorsements and a successful face-to-face training rollout.
Ada Torres
Ada Torres
7 Oct 2025
Vanguard Investments Australia has announced the Distribution Reinvestment Plan (DRP) issue prices for its suite of ETFs for the quarter ending 30 September 2025, outlining key dates and eligibility for investors.
Claire Turing
Claire Turing
2 Oct 2025
BPH Global Ltd reports steady seaweed sales of A$222,656 for August, supported by a fully operational warehouse in Makassar and ongoing partnerships in Indonesia.
Ada Torres
Ada Torres
2 Oct 2025
ImpediMed secures expanded insurance reimbursement for its SOZO platform, now covering over 301 million US lives and enhancing early detection of breast cancer-related lymphedema.
Ada Torres
Ada Torres
2 Oct 2025